Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Growth Expected to Reach $149.68 Billion by 2030 with 40.2% CAGR
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market During 2026–2030?
The robot-assisted percutaneous coronary intervention (pci) market has experienced significant expansion in recent years. It is projected to increase from $27.56 billion in 2025 to $38.73 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 40.5%. This historical expansion is linked to factors such as an increase in coronary artery disease prevalence, the inherent limitations of manual pci precision, the growing adoption of catheter-based interventions, a heightened awareness of radiation risks, and the expansion of cardiac catheterization laboratories.
The robot-assisted percutaneous coronary intervention (pci) market is projected to experience rapid expansion over the coming years. This market is anticipated to reach $149.68 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 40.2%. Key drivers for this expansion during the projection period include progress in robotic-assisted intervention technologies, greater embrace of automation within cardiology, increased funding for digital healthcare infrastructure, a surging need for intricate and high-risk pci procedures, and favorable regulatory endorsements for robotic platforms. Significant trends expected in the upcoming period encompass a higher uptake of minimally invasive cardiac interventions, an intensified focus on lowering radiation exposure for medical professionals, a greater requirement for precision and accuracy in procedures, an increase in complex coronary intervention capacities, and enhanced patient safety with better clinical results.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27408&type=smp
Which Economic Or Industry Drivers Are Impacting The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?
The anticipated expansion of the robot-assisted percutaneous coronary intervention (PCI) market is driven by the rising occurrence of cardiovascular diseases. These conditions encompass a range of heart and blood vessel disorders, such as coronary artery disease, heart attacks, and stroke. A primary contributor to the increase in cardiovascular diseases is inactive lifestyles, which frequently result in obesity, high blood pressure, and compromised heart well-being. Robot-assisted percutaneous coronary intervention (PCI) offers a treatment for cardiovascular diseases by precisely unblocking or widening coronary arteries to reestablish blood flow to the heart, simultaneously minimizing procedural dangers and radiation, and ultimately improving patient results. As an illustration, GOV.UK, a UK government agency, reported in December 2024 that approximately 2.24 million adults in England, representing about 4.4% of individuals aged 18 and over, received a GP diagnosis of CKD in March 2024. This figure marks an increase from 2.09 million cases reported in the preceding year. Consequently, the expanding occurrence of cardiovascular diseases is a key factor propelling the development of the robot-assisted percutaneous coronary intervention (PCI) market.
How Are The Various Segments Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Categorized?
The robot-assisted percutaneous coronary intervention (pci) market covered in this report is segmented –
1) By Component: Robotic Systems, Catheters And Guidewires, Control Consoles
2) By Application: Coronary Angioplasty, Stent Placement, Thrombectomy
3) By End-User: Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Robotic Systems: Electromechanical Robotic Arms, Imaging Integration Units, Robotic Drive Systems
2) By Catheters And Guidewires: Coronary Guidewires, Balloon Catheters, Drug-Eluting Catheters
3) By Control Consoles: Touchscreen Interfaces, Joystick Controllers, Imaging Display Panels
What Trends Are Affecting The Expansion Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?
Leading companies operating in the robot-assisted percutaneous coronary intervention (PCI) market are concentrating on developing advanced robotic cardiologist platforms to enhance patient safety and streamline complex coronary interventions. A robotic cardiology platform functions as a high-technology system that assists cardiologists in performing accurate and controlled coronary procedures, thereby boosting precision, minimizing human error, and reducing radiation exposure for patients and medical staff. For example, in May 2023, Robocath SAS, a France-based company specializing in robotic solutions for vascular interventions, introduced the R-One+. This sophisticated robotic solution allows interventional cardiologists to execute coronary angioplasties (percutaneous coronary intervention, or PCI) by managing devices through an integrated command unit located within the catheterization lab or control room. The R-One+ improves precision in device manipulation, enhances safety for both patients and medical staff by decreasing radiation exposure, and offers more comfortable working conditions for operators. The launch was announced at the EuroPCR conference in Paris, where the platform demonstrated new capabilities designed to make PCI procedures simpler and safer while shielding the cardiology team from radiation-induced injuries. This innovation underscores Robocath’s commitment to advancing cardiovascular disease treatments with intelligent robotic assistance.
Which Major Firms Influence Developments In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?
Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc., AngioDynamics, Clear Surgical Inc., GE Healthcare, Canon Medical Systems, Asensus Surgical, Endovascular Robotics
Read the full robot-assisted percutaneous coronary intervention (pci) market report here:
What Are The Top-Performing Regions Within The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?
North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (pci) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27408&type=smp
Browse Through More Reports Similar to the Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market 2026, By The Business Research Company
Post Consumer Recycled Plastics Market Report 2026
Plastic Recycling Market Report 2026
https://www.thebusinessresearchcompany.com/report/plastic-recycling-global-market-report
Asphalt Shingles Market Report 2026
https://www.thebusinessresearchcompany.com/report/asphalt-shingles-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
